comparemela.com

Latest Breaking News On - 340b program - Page 2 : comparemela.com

Bon Secours under investigation by US Senate: What ASCs should know

U.S. Senate committee led by Louisiana Sen. Bill Cassidy is investigating Cincinnati-based Bon Secours Mercy Health s use of the government s 340B program, whic

United statesNew yorkBill cassidyBon secourBon secoursRichmond va community hospitalNew york timesSenate committee on healthBon secours mercy healthUs senateCincinnati based bon secours mercy healthCompass surgicalSenate committeeCommunity hospitalCleveland clinicMercy health

Health system execs add revenue with clinical innovation

Hospitals and health systems are looking for ways to increase revenue while improving patient care. Innovations such as digital transformation, AI-powered clini

New yorkUnited statesRandolph siwabessyKatie barrDavid reichHealth in orangeN advocate healthMount sinai hospitalMount sinai queensAdvocate healthClinical careValue based care340b programCell based therapiesNovel antibody therapiesDigital transformation

NC lawmaker: Your drug prices will rise if Congress messes with this drug pricing program

NC lawmaker: Congress must keep its hands off this drug pricing program, NC patients will suffer. | Opinion

United statesNorth carolinaWayne sasserB drug pricing programNorth caroliniansTar heelDrug pricing programPrescription drugs340b programHealthcare outcomesRural hospitalsNorth caroliniansHealthcare facilitiesThe programHealthcare disparities

Viewpoint: NEJM article uses sketchy math to attack hospitals

The American Hospital Association responds to an article claiming hospitals don t deserve their 340B tax exemption, citing the sector s contributions to communities with vulnerable populations.

American hospital associationDistrict of columbiaUnited statesGeorgetown university law centerMelinda hattonDavid hymanSunjay letchumanJohns hopkins bloomberg school of public healthJohns hopkins carey business schoolNew england journalNonprofit hospitals deserve their taxArnold venturesJohns hopkins bloomberg schoolPublic healthNew york city based icahn schoolMount sinai

340B Program May Be Reducing Biosimilar Uptake

New research has found the 340B program is slowing uptake of biosimilars by incentivizing use of more expensive biologics.

United statesNew yorkSteinzorp nicolas ferreyrosThe new york timesBon secours mercy healthHealth affairsB drug pricing programCommunity oncology allianceHealth aff millwoodNew york timesDrug pricing programBiologics price competitionAmerican journal340b program

vimarsana © 2020. All Rights Reserved.